Ischemic Stroke May Increase the Risk of Crohn's Disease and Ulcerative Colitis: Evidence from a Bidirectional

Xin Luo1, Liping Yao1, Yinchao Chen1

  • 1The Third Hospital of Changsha (Changsha Hospital Affiliated to Hunan University), Changsha City, Hunan Province, People's Republic of China.

World Neurosurgery
|February 10, 2025
PubMed

Insights

Ischemic stroke (IS) increases the risk of Crohn's disease (CD) and ulcerative colitis (UC). However, inflammatory bowel disease (IBD) does not appear to cause IS. Monitor IBD risks in IS patients.

Area of Science:

  • Genetics
  • Epidemiology
  • Internal Medicine

Background:

  • The causal link between ischemic stroke (IS) and inflammatory bowel disease (IBD) is not well understood.
  • A bidirectional Mendelian randomization (MR) study was proposed to investigate this relationship.

Purpose of the Study:

  • To determine if IS causes IBD or if IBD causes IS.
  • To explore the bidirectional causal relationship between IS and IBD, including its subtypes Crohn's disease (CD) and ulcerative colitis (UC).

Main Methods:

  • Utilized large-scale genetic data from the MEGASTROKE consortium and the International Inflammatory Bowel Disease Genetics Consortium.
  • Employed inverse variance weighting (IVW) as the primary analysis, with MR-Egger regression, weighted median, MR-PRESSO, and MR-Robust adjusted profile score for sensitivity analyses.
  • Conducted a meta-analysis combining data from the International Inflammatory Bowel Disease Genetics Consortium and the FinnGen database for robust causal association assessment.

Main Results:

  • Ischemic stroke (IS) was found to be causally associated with an increased risk of Crohn's disease (CD) (OR IVW = 1.38) and ulcerative colitis (UC) (OR IVW = 1.27).
  • No significant causal relationship was observed between IBD (as a whole or its subtypes) and the risk of IS.
  • Replication phase using FinnGen data did not reveal significant correlations, but combined meta-analysis supported IS as a risk factor for CD and UC.

Conclusions:

  • Ischemic stroke (IS) is causally linked to an increased risk of developing Crohn's disease (CD) and ulcerative colitis (UC).
  • Inflammatory bowel disease (IBD) and its subtypes were not found to be causally associated with the risk of IS.
  • Close monitoring for CD and UC is recommended for patients with a history of IS.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
384
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
126
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
171
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
304